Maternal RSV immunization creates an important opportunity for obstetric and pediatric clinicians to coordinate newborn prevention strategies, according to Kevin Ault, MD.
News|Articles|February 18, 2026 (Updated: February 18, 2026)
ACOG updates maternal immunization guidance
Author(s)Joshua Fitch, Senior Editor
Fact checked by: Benjamin P. Saylor
The updated Committee Statement reaffirmed the safety and benefits of influenza, COVID-19, Tdap, and RSV vaccines during pregnancy while addressing misinformation and disparities.
Advertisement
Advertisement
The American College of Obstetricians & Gynecologists (ACOG) released updated guidance on maternal immunizations, reinforcing the importance of routine vaccination during pregnancy to protect both pregnant individuals and their infants. The Committee Statement was published February 18, 2026, in Obstetrics & Gynecology.1,2
Related to this article
Drawing on her own successful version, Amber Watters, MD, welcomes the ASA's push for closer obstetrics and anesthesia collaboration.
SMFM states abortion care is core to MFM practice and urges institutional action to protect high-risk patient access.
Kevin Ault, MD, FACOG, explains that all four vaccines in ACOG's 2026-27 guidance carry direct newborn benefit and that prenatal conversations ease downstream pediatric vaccine discussions.
Kevin Ault, MD, FACOG, emphasizes that obstetric clinicians are patients' most trusted vaccine information source, making maternal COVID-19 counseling a high-value opportunity.
FDA granted BTD to certolizumab pegol for preventing adverse pregnancy outcomes in women with antiphospholipid syndrome.
Amber Watters, MD, MS, explains how the ASA's statement encourages obstetric units to integrate neuraxial anesthesia into a formal external cephalic version process.
Placentas from older mothers held less NAD+, and in aged pregnant mice, nicotinamide riboside or the CD38 inhibitor 78c restored placental NAD+ and improved fetal growth.
Advertisement
Advertisement